Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment
Clinical trial NCT07463807 · RECRUITING
Trial details
- NCT number
- NCT07463807
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2027-04-12
- Primary completion
- 2029-03-31
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.